Are you Ready for the Renaissance in Small Molecule Drug Discovery?
At first glance, it might seem that small molecule discovery has reached a plateau. In reality, the truth couldn’t be more different. With small molecules making up over 60% of new drug approvals in 2021, it’s clear that the appetite for progression and potential for innovation is huge. The renaissance of small molecule drug discovery…